210 related articles for article (PubMed ID: 29438808)
1. Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1-2 COPD.
Porszasz J; Carraro N; Cao R; Gore A; Ma S; Jiang T; Maltais F; Ferguson GT; O'Donnell DE; Shaikh A; Rossiter HB; Casaburi R
Respir Physiol Neurobiol; 2018 May; 251():8-15. PubMed ID: 29438808
[TBL] [Abstract][Full Text] [Related]
2. Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method.
Ma S; Hecht A; Varga J; Rambod M; Morford S; Goto S; Casaburi R; Porszasz J
Respir Med; 2010 Mar; 104(3):389-96. PubMed ID: 19931441
[TBL] [Abstract][Full Text] [Related]
3. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
[TBL] [Abstract][Full Text] [Related]
4. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
Rossi A; Centanni S; Cerveri I; Gulotta C; Foresi A; Cazzola M; Brusasco V
Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851
[TBL] [Abstract][Full Text] [Related]
6. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
7. Relation of concavity in the expiratory flow-volume loop to dynamic hyperinflation during exercise in COPD.
Varga J; Casaburi R; Ma S; Hecht A; Hsia D; Somfay A; Porszasz J
Respir Physiol Neurobiol; 2016 Dec; 234():79-84. PubMed ID: 27575552
[TBL] [Abstract][Full Text] [Related]
8. Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
Watz H; Mailänder C; May C; Baier M; Kirsten AM
Pulm Pharmacol Ther; 2017 Feb; 42():13-20. PubMed ID: 27940287
[TBL] [Abstract][Full Text] [Related]
9. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.
Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D
Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204
[TBL] [Abstract][Full Text] [Related]
10. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
12. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
13. Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide.
Verbanck S; Schuermans D; Vincken W
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):625-34. PubMed ID: 18268937
[TBL] [Abstract][Full Text] [Related]
14. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
[TBL] [Abstract][Full Text] [Related]
15. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
[TBL] [Abstract][Full Text] [Related]
16. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
17. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
18. Predicting the response to a bronchodilator in patients with airflow obstruction and lung cancer.
Ueda K; Murakami J; Tanaka T; Yoshida K; Kobayashi T; Hamano K
J Surg Res; 2018 Aug; 228():20-26. PubMed ID: 29907212
[TBL] [Abstract][Full Text] [Related]
19. Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD.
Gelb AF; Fraser C; Zamel N
Respir Med; 2011 May; 105(5):755-60. PubMed ID: 21159499
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
